Recruiting
Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel
NCT06947668
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +9 more
- Locations
-
- Universitätsklinikum Erlangen, Strahlenklinik Erlangen, Bavaria, Germany